Niemann Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Niemann Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-53,417	Closed	-$6.63M	–	17
2015 Q2	$6.63M	Sell	53,417 -4,371	-8%	-$528K	4.73%	8
2015 Q1	$6.83M	Sell	57,788 -1,114	-2%	-$126K	4.61%	8
2014 Q4	$6.01M	Buy	+58,902	New	+$5.75M	4.27%	9

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TFA

Transamerica Financial Advisors St. Petersburg, Florida $1.17B AUM 23.36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Niemann Capital Management's FBT Position: Q3 2015 in Review

Niemann Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2015, closing a stake of 53,417 shares — an estimated $6.63M sold.

Niemann Capital Management first reported a position in FBT in Q4 2014 and held it in 3 quarters. The position peaked at $6.83M in Q1 2015. 126 funds tracked by Wall St. Rank hold FBT as of Q3 2015.

Niemann Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2015 after selling out during the quarter.
Niemann Capital Management sold 53,417 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2015, an estimated $6.63M.
Niemann Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2014 and held it in 3 quarters.
Niemann Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $6.83M in Q1 2015.
126 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2015.

Based on Niemann Capital Management's 13F filing for Q3 2015, filed 9 Nov 2015.